Kabra Drugs LimitedBSE: KABRADG

Kabra Drugs Limited Press Release Apr 07 2026

· Issued by Kabra Drugs Limited via BSE India

Filed with BSE · · 2 pages · English

We enclose herewith a certificate issued by Skyline Financial Services Pvt Ltd, Registrar and Share Transfer Agent of the Company confirming the compliance under the Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018 for the quarter ended 31st March 2026. Nanjappan Aravind Managing Director

Kabra Drugs Limited on 6ix

Earlier from Kabra Drugs

Later from Kabra Drugs

All Kabra Drugs news releases